Literature DB >> 27385018

Immune reconstitution post allogeneic transplant and the impact of immune recovery on the risk of infection.

Rohtesh S Mehta1, Katayoun Rezvani2.   

Abstract

Infection is the leading cause of non-relapse mortality after allogeneic haematopoietic cell transplantation (HCT). This occurs as a result of dysfunction to the host immune system from the preparative regimen used prior to HCT, combined with a delay in reconstitution of the donor-derived immune system after HCT. In this article, we elaborate on the process of immune reconstitution post-HCT that begins with the innate system and is followed by recovery of adaptive immunity. Simultaneously, we describe how the tempo of immune reconstitution influences the risk of various infections. We explain some of the key differences in immune reconstitution and the consequent risk of infections in recipients of peripheral blood stem cell, bone marrow or umbilical cord blood grafts. Other factors that impact on immune recovery are also highlighted. Finally, we allude to various strategies that are being tested to enhance immune reconstitution post-HCT.

Entities:  

Keywords:  adaptive immunity; allogeneic haematopoietic stem cell transplant; immune reconstitution; infection; innate immunity

Mesh:

Year:  2016        PMID: 27385018      PMCID: PMC5160395          DOI: 10.1080/21505594.2016.1208866

Source DB:  PubMed          Journal:  Virulence        ISSN: 2150-5594            Impact factor:   5.882


  174 in total

1.  Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantation.

Authors:  Johannes L Zakrzewski; Adam A Kochman; Sydney X Lu; Theis H Terwey; Theo D Kim; Vanessa M Hubbard; Stephanie J Muriglan; David Suh; Odette M Smith; Jeremy Grubin; Neel Patel; Andrew Chow; Javier Cabrera-Perez; Radhika Radhakrishnan; Adi Diab; Miguel-Angel Perales; Gabrielle Rizzuto; Ewa Menet; Eric G Pamer; Glen Heller; Juan Carlos Zúñiga-Pflücker; Onder Alpdogan; Marcel R M van den Brink
Journal:  Nat Med       Date:  2006-08-27       Impact factor: 53.440

2.  CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity.

Authors:  Todd A Fehniger; Megan A Cooper; Gerard J Nuovo; Marina Cella; Fabio Facchetti; Marco Colonna; Michael A Caligiuri
Journal:  Blood       Date:  2002-12-12       Impact factor: 22.113

3.  High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution.

Authors:  Suparno Chakrabarti; Stephen Mackinnon; Raj Chopra; Panagiotis D Kottaridis; Karl Peggs; Peter O'Gorman; Ronjon Chakraverty; Timothy Marshall; Husam Osman; Premini Mahendra; Charles Craddock; Herman Waldmann; Geoff Hale; Christopher D Fegan; Kwee Yong; Anthony H Goldstone; David C Linch; Donald W Milligan
Journal:  Blood       Date:  2002-06-15       Impact factor: 22.113

4.  Varicella zoster infection after bone marrow transplantation: incidence, risk factors and complications.

Authors:  C S Han; W Miller; R Haake; D Weisdorf
Journal:  Bone Marrow Transplant       Date:  1994-03       Impact factor: 5.483

5.  Antibody responses to vaccinations given within the first two years after transplant are similar between autologous peripheral blood stem cell and bone marrow transplant recipients.

Authors:  M K Gandhi; W Egner; L Sizer; I Inman; M Zambon; J I Craig; R E Marcus
Journal:  Bone Marrow Transplant       Date:  2001-10       Impact factor: 5.483

6.  Outcomes, infections, and immune reconstitution after double cord blood transplantation in patients with high-risk hematological diseases.

Authors:  A Ruggeri; R Peffault de Latour; M Carmagnat; E Clave; C Douay; J Larghero; J-M Cayuela; R Traineau; M Robin; A Madureira; P Ribaud; C Ferry; A Devergie; D Purtill; C Rabian; E Gluckman; A Toubert; G Socié; V Rocha
Journal:  Transpl Infect Dis       Date:  2011-04-05       Impact factor: 2.228

Review 7.  Fungal infections after bone marrow transplant.

Authors:  J R Wingard
Journal:  Biol Blood Marrow Transplant       Date:  1999       Impact factor: 5.742

8.  NK cells contribute to intracellular bacterial infection-mediated inhibition of allergic responses.

Authors:  Xiaobing Han; Yijun Fan; Shuhe Wang; Lei Jiao; Hongyu Qiu; Xi Yang
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

9.  Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment.

Authors:  R P Witherspoon; R Storb; H D Ochs; N Fluornoy; K J Kopecky; K M Sullivan; J H Deeg; R Sosa; D R Noel; K Atkinson; E D Thomas
Journal:  Blood       Date:  1981-08       Impact factor: 22.113

10.  Activation of natural killer cells during microbial infections.

Authors:  Amir Horowitz; Kerstin A Stegmann; Eleanor M Riley
Journal:  Front Immunol       Date:  2012-01-03       Impact factor: 7.561

View more
  41 in total

1.  Adoptive therapy with CMV-specific cytotoxic T lymphocytes depends on baseline CD4+ immunity to mediate durable responses.

Authors:  Vanessa A Fabrizio; M Irene Rodriguez-Sanchez; Audrey Mauguen; Parastoo B Dahi; Ekaterina Doubrovina; Richard J O'Reilly; Susan E Prockop
Journal:  Blood Adv       Date:  2021-01-26

2.  A short tale of blood, kidney and brain: BK virus encephalitis in an allogeneic stem cell transplant recipient.

Authors:  C Bourlon; S Alamoudi; D Kumar; A Viswabandya; S Thyagu; F V Michelis; D D-H Kim; J H Lipton; H A Messner; U Deotare
Journal:  Bone Marrow Transplant       Date:  2017-02-20       Impact factor: 5.483

3.  Infections following allogeneic stem cell transplantation: New concepts, improved insights, and renewed hope for better outcomes.

Authors:  Dimitrios P Kontoyiannis
Journal:  Virulence       Date:  2016-11-16       Impact factor: 5.882

4.  How I transplant a patient with a history of invasive fungal disease.

Authors:  Pedro Puerta-Alcalde; Richard Champlin; Dimitrios P Kontoyiannis
Journal:  Blood       Date:  2020-08-26       Impact factor: 22.113

5.  Kinetics of immune cell reconstitution predict survival in allogeneic bone marrow and G-CSF-mobilized stem cell transplantation.

Authors:  Edmund K Waller; Brent R Logan; Mingwei Fei; Stephanie J Lee; Dennis Confer; Alan Howard; Shanmuganathan Chandrakasan; Claudio Anasetti; Shanelle M Fernando; Cynthia R Giver
Journal:  Blood Adv       Date:  2019-08-13

6.  How I perform hematopoietic stem cell transplantation on patients with a history of invasive fungal disease.

Authors:  Pedro Puerta-Alcalde; Richard E Champlin; Dimitrios P Kontoyiannis
Journal:  Blood       Date:  2020-12-10       Impact factor: 22.113

7.  MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD.

Authors:  Hannah Major-Monfried; Anne S Renteria; Attaphol Pawarode; Pavan Reddy; Francis Ayuk; Ernst Holler; Yvonne A Efebera; William J Hogan; Matthias Wölfl; Muna Qayed; Elizabeth O Hexner; Kitsada Wudhikarn; Rainer Ordemann; Rachel Young; Jay Shah; Matthew J Hartwell; Mohammed S Chaudhry; Mina Aziz; Aaron Etra; Gregory A Yanik; Nicolaus Kröger; Daniela Weber; Yi-Bin Chen; Ryotaro Nakamura; Wolf Rösler; Carrie L Kitko; Andrew C Harris; Michael Pulsipher; Ran Reshef; Steven Kowalyk; George Morales; Ivan Torres; Umut Özbek; James L M Ferrara; John E Levine
Journal:  Blood       Date:  2018-03-15       Impact factor: 22.113

Review 8.  NK cell therapy for hematologic malignancies.

Authors:  Rohtesh S Mehta; Brion Randolph; May Daher; Katayoun Rezvani
Journal:  Int J Hematol       Date:  2018-01-27       Impact factor: 2.490

9.  Superior immune reconstitution using Treg-expanded donor cells versus PTCy treatment in preclinical HSCT models.

Authors:  Dietlinde Wolf; Cameron S Bader; Henry Barreras; Sabrina Copsel; Brent J Pfeiffer; Casey O Lightbourn; Norman H Altman; Krishna V Komanduri; Robert B Levy
Journal:  JCI Insight       Date:  2018-10-18

10.  Killer Immunoglobulin-Like Receptor-Ligand Interactions Predict Clinical Outcomes following Unrelated Donor Transplantations.

Authors:  Elizabeth Krieger; Roy Sabo; Sanauz Moezzi; Caitlin Cain; Catherine Roberts; Pamela Kimball; Alden Chesney; John McCarty; Armand Keating; Rizwan Romee; Christina Wiedl; Rehan Qayyum; Amir Toor
Journal:  Biol Blood Marrow Transplant       Date:  2019-10-30       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.